Legumain, a tumor-associated antigen, has been widely investigated in human oncology to determine its malignant roles and its potential tumor-promoting mechanisms; however, few studies have considered the expression of legumain in tumor-bearing dogs. The gene discussed is LGMN; the disease is neoplasm.